Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Clostridium difficile in the ICU: The struggle continues
Linda D. Bobo
,
Erik R. Dubberke
,
Marin Kollef
Division of Infectious Diseases
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Division of Pulmonary & Critical Care Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
64
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clostridium difficile in the ICU: The struggle continues'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clostridium Difficile Infection
100%
Clostridioides Difficile
100%
Clinical Management
11%
Management Strategy
11%
Infection Rate
11%
Possible Causes
11%
Treatment Regimen
11%
Difficile
11%
Vancomycin
11%
Management Guidelines
11%
Healthcare
11%
Primary Infection
11%
Current Management
11%
Intestinal Flora
11%
Infection Severity
11%
Infectious Diseases Society of America
11%
Prevention Guidelines
11%
ICU Admission
11%
Mild Symptoms
11%
Hypervirulent
11%
Infection Management
11%
Metronidazole
11%
Healthcare Economics
11%
Infection Diagnosis
11%
Treatment First
11%
Changing Epidemiology
11%
Attributable Mortality
11%
Nonbacterial
11%
Medicine and Dentistry
Peptoclostridium difficile
100%
Clostridium Difficile Infection
100%
Cohort Effect
11%
Vancomycin
11%
Clinical Management
11%
Infectious Disease
11%
Metronidazole
11%
Health Care Economics
11%
Primary Infection
11%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Difficile Infection
100%
Peptoclostridium difficile
100%
Primary Infection
11%
Intestine Flora
11%
Vancomycin
11%
Metronidazole
11%
Diseases
11%
Immunology and Microbiology
Peptoclostridium difficile
100%
Infection
100%
Intestine Flora
10%
Cohort Effect
10%
Nursing and Health Professions
Clostridium Difficile Infection
100%
Practice Guideline
11%
Vancomycin
11%
Health Care Cost
11%
Clinical Management
11%
Metronidazole
11%
Primary Infection
11%
Diseases
11%